Screening algorithms for HBV, HCV, HIV and syphilis in an anatomical donation program

被引:2
|
作者
Valcke, Brecht [1 ]
Vercauteren, Koen [2 ]
Padalko, Elizaveta [3 ]
Verhofstede, Chris [4 ]
D'Herde, Katharina [1 ]
Willaert, Wouter [1 ]
机构
[1] Univ Ghent, Dept Human Struct & Repair, Corneel Heymanslaan 10, B-9000 Ghent, Belgium
[2] Inst Trop Med, Clin Virol Unit, Clin Reference Lab, Kronenburgstr 43, B-2000 Antwerp, Belgium
[3] Ghent Univ Hosp, Lab Med Microbiol, Corneel Heymanslaan 10, B-9000 Ghent, Belgium
[4] Univ Ghent, Dept Diagnost Sci, Aids Reference Lab, Corneel Heymanslaan 10, B-9000 Ghent, Belgium
关键词
Anatomy; Cadaver; Embalming; Hemolysis; Hepatitis B virus; Hepatitis C virus; Human immunodeficiency virus; HUMAN-IMMUNODEFICIENCY-VIRUS; HEPATITIS-B; POSTMORTEM VIABILITY; TREPONEMA-PALLIDUM; BLOOD-SAMPLES; CADAVER; TRANSMISSION; PREVALENCE; SURVIVAL; DISCARDS;
D O I
10.1016/j.aanat.2021.151805
中图分类号
R602 [外科病理学、解剖学]; R32 [人体形态学];
学科分类号
100101 ;
摘要
Background: Users of anatomical donors are at risk of exposure to bloodborne pathogens. This study evaluated screening algorithms for hepatitis B and C virus, human immunodeficiency virus and Treponema pallidum during donor allocation and assessed the impact of postmortem time on hemolysis and how hemolysis affects test results and donor discard rate. Methods: From 2011 to 2018, demographic data of anatomical donors, time of postmortem blood sampling, presence of sample hemolysis, serological test results (negative; active infection; false reactive screening test; historic infection; inconclusive; technically impracticable) and the actual donor allocation were collected. Results: Donors (n = 537) had a mean age of 77.53 +/- 13.67 (24-103) year. Nine (1.68%) had laboratory test results indicative for active infection for hepatitis B (n = 1) and C virus (n = 2), human immunodeficiency virus (n = 5) and T. pallidum (n = 1). Negative screenings ranged from 74.67 to 97.58%, depending on the pathogen. According to the original screening algorithms, 479 (89.20%) donors should have been accepted. In practice, a donor acceptance rate of 91.20% was found. Analysis of potential donor allocation interpretation obstacles resulted in simplification of the in-house laboratory testing algorithms and addition of a nucleic acid test to increase the reliability for identification of active (acute) human immunodeficiency virus infection. Hemolysis was more common when sampling was performed more than 24 h after death (p < 0.001). Hemolytic samples more frequently showed a reactive or indeterminate human immunodeficiency virus test result (p < 0.001). Screening for human immunodeficiency virus and T. pallidum was technically more impracticable when hemolysis was present (p = 0.042 and p = 0.003, respectively). Donors with hemolytic blood samples were more often discarded (46.88%) compared to bodies with non-hemolytic samples (6.32%) (p < 0.001). Conclusions: Despite the implementation of donor screening algorithms, a significant number of bodies have an inconsistent allocation. New algorithms, to be evaluated in future research, were suggested. Early postmortem blood sampling is key as hemolysis can influence certain test results and donor allocation. (c) 2021 Elsevier GmbH. All rights reserved.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] HIV, HBV, AND HCV Screening with NATAND Serology in the OPO Setting.
    Theodoropoulos, Nicole
    Ison, Michael G.
    TRANSPLANTATION, 2018, 102 : S57 - S57
  • [22] HIV, HBV, and HCV Screening with NAT and Serology in the OPO Setting.
    Theodoropoulos, N.
    Ison, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 461 - 462
  • [23] Evaluating the Return Rates of Donors Eligible for Re-entry After a Falsely Positive Screening Test for Syphilis, HCV, HBV, and HIV
    Delage, G.
    Gregoire, Y.
    Germain, M.
    TRANSFUSION, 2015, 55 : 43A - 43A
  • [24] Review of sociodemographic characteristics of blood donors with HIV/HBV or HIV/HCV or HBV/HCV CO infection referred to donation centers of Tehran from February 2006 to February 2007
    Zadsar, M.
    Rad, Rastegar N.
    VOX SANGUINIS, 2008, 95 : 103 - 103
  • [25] Is there a need to include HIV, HBV and HCV viruses in the Saudi premarital screening program on the basis of their prevalence and transmission risk factors?
    Alswaidi, F. M.
    O'Brien, S. J.
    JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2010, 64 (11) : 989 - 997
  • [26] HIV, HCV, HBV and syphilis surveillance among blood donors in Germany 2008-2010
    Offergeld, R.
    Ritter, S.
    Hamouda, O.
    BUNDESGESUNDHEITSBLATT-GESUNDHEITSFORSCHUNG-GESUNDHEITSSCHUTZ, 2012, 55 (08) : 907 - 913
  • [27] HBV, HCV, or syphilis coinfection with HIV in pregnant women seen at the main hospital in the capital of Venezuela
    Garcia, Yoel D.
    Urena, Francisco A.
    Carrion-Nessi, Fhabian S.
    Diaz, Sol Y.
    Avila, Atahualpa A.
    Omana-Avila, Oscar D.
    Freitas-De Nobrega, Diana C.
    Guilliod-Grossmann, Christian R.
    Soto, Lily M.
    Carballo, Martin
    Landaeta, Maria E.
    Forero-Pena, David A.
    HIV MEDICINE, 2023, 24 (03) : 372 - 375
  • [28] Single donation genomic screening for HCV and HIV RNA in England: A comparison with pool testing for HCV RNA
    Candotti, D
    Sims, C
    Cant, B
    Reeves, I
    Barbara, JJ
    Allain, J
    TRANSFUSION, 2000, 40 (10) : 9S - 9S
  • [29] Universal screening versus universal precautions in the context of preoperative screening for HIV, HBV, HCV in India
    Ahmed, R.
    Bhattacharya, S.
    INDIAN JOURNAL OF MEDICAL MICROBIOLOGY, 2013, 31 (03) : 219 - 225
  • [30] Reflections on implementation of HBV, HCV, and HIV nucleic acid testing in blood screening
    Laperche, S
    TRANSFUSION CLINIQUE ET BIOLOGIQUE, 1998, 5 (02) : 139 - 146